Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
University of Sharjah currently has 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are being reviewed by 7 distinct examiners, which shows that each pending matter is assigned to a different individual. This distribution indicates that the university's prosecution experience is spread across a wide range of examiner perspectives.
The portfolio is active in 6 distinct art units, reflecting a high degree of technical diversity within the university's biotechnology and pharmaceutical research. COLEMAN, CHARLES P. is the busiest examiner for the university, currently overseeing 1 pending office action. Because each of the 7 distinct examiners is handling only 1 pending office action, there is no concentration of workload under any single person. The university's 7 pending office actions are distributed across 6 distinct art units, requiring a strategy that addresses the specific technical and procedural nuances of nearly as many art units as there are active applications.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (14%) |
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLEMAN, CHARLES P. | 1 | 16.0% | +19.3% |
| CALLE, ANGEL JAVIER | 1 | 69.6% | +27.7% |
| TOWNSLEY, SARA ELIZABETH | 1 | 25.5% | +49.1% |
| KIM, TAEYOON | 1 | 51.5% | +52.1% |
| WU, RUTAO | 1 | 39.4% | +23.6% |
| SITTON, JEHANNE SOUAYA | 1 | 53.2% | +48.0% |
| LEE, WILLIAM Y | 1 | 47.9% | +34.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16562861 | DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA | SITTON, JEHANNE SOUAYA | 28d |
| 18123009 | PYRIDOPYRIDINES AND DERIVATIVES THEREOF AS SELECTIVE KINASE INHIBITORS | TOWNSLEY, SARA ELIZABETH | 83d |
| 19008867 | SURGICAL INVENTORY CONTROL SYSTEM | COLEMAN, CHARLES P. | — |
| 18035103 | A METHOD OF EVALUATING CIRCUIT PROTECTION OF A POWER NETWORK | CALLE, ANGEL JAVIER | — |
| 18089098 | AUTONOMOUS KNOWLEDGE-BASED SMART WASTE COLLECTION SYSTEM | WU, RUTAO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18098994 | Development of decellularized bovine bone graft | KIM, TAEYOON | 85d overdue |
| 16562861 | DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA | SITTON, JEHANNE SOUAYA | 28d |
| 18123009 | PYRIDOPYRIDINES AND DERIVATIVES THEREOF AS SELECTIVE KINASE INHIBITORS | TOWNSLEY, SARA ELIZABETH | 83d |
| 19008867 | SURGICAL INVENTORY CONTROL SYSTEM | COLEMAN, CHARLES P. | — |
| 18035103 | A METHOD OF EVALUATING CIRCUIT PROTECTION OF A POWER NETWORK | CALLE, ANGEL JAVIER | — |
| 18089098 | AUTONOMOUS KNOWLEDGE-BASED SMART WASTE COLLECTION SYSTEM | WU, RUTAO | — |
| 15516444 | ATROPINE SULFATE RAPIDLY-DISINTEGRATING SUBLINGUAL TABLETS AND METHODS FOR USE THEREOF FOR TREATMENT OF ACUTE ORGANOPHOSPHATE TOXICITY | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 3683 | 1 |
| 1629 | 1 |
| 1631 | 1 |
| 3623 | 1 |
| 1682 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19008867 | SURGICAL INVENTORY CONTROL SYSTEM | COLEMAN, CHARLES P. | 3683 | §101 | Final Rejection | — | Pending | Jan 03, 2025 |
| 18035103 | A METHOD OF EVALUATING CIRCUIT PROTECTION OF A POWER NETWORK | CALLE, ANGEL JAVIER | — | §102§103 | Non-Final OA | — | Pending | May 02, 2023 |
| 18123009 | PYRIDOPYRIDINES AND DERIVATIVES THEREOF AS SELECTIVE KINASE INHIBITORS | TOWNSLEY, SARA ELIZABETH | 1629 | §112 | Non-Final OA | 83d | Pending | Mar 17, 2023 |
| 18098994 | Development of decellularized bovine bone graft | KIM, TAEYOON | 1631 | §103 | Final Rejection | 85d overdue | Pending | Jan 19, 2023 |
| 18089098 | AUTONOMOUS KNOWLEDGE-BASED SMART WASTE COLLECTION SYSTEM | WU, RUTAO | 3623 | §103§112 | Final Rejection | — | Pending | Dec 27, 2022 |
| 16562861 | DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA | SITTON, JEHANNE SOUAYA | 1682 | §101§103 | Non-Final OA | 28d | Pending | Sep 06, 2019 |
| 15516444 | ATROPINE SULFATE RAPIDLY-DISINTEGRATING SUBLINGUAL TABLETS AND METHODS FOR USE THEREOF FOR TREATMENT OF ACUTE ORGANOPHOSPHATE TOXICITY | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | — | Pending | Apr 03, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial